Die selbstständige Blutzuckerkontrolle ist für viele Patienten mit Diabetes mellitus heute ein fester Bestandteil des Krankheitsmanagements. Eine kontinuierliche interstitielle Glukosemessung ermöglicht eine weitere Verbesserung der Dosisanpassung bei Patienten unter intensivierter konventioneller Insulinbehandlung und bei Patienten mit Insulinpumpen.
Abstract
Today, self-measurement of glucose concentrations represents an integral part in disease management for many patients with diabetes mellitus. Starting with urine glucose test stripes about 50 years ago, patients were enabled to perform measurements of glucose control by their own. Proceeding from urine glucose measurements to capillary blood glucose in the 1960ies provided totally new opportunities and created the basis for modern intensified insulin treatment with an adaptation of insulin dosages according to actual blood glucose concentrations. Today, we are moving from punctual capillary blood glucose measurements to continuous measurement of glucose concentrations in the interstitial fluid. Again, opening a new century of glucose control for patients with diabetes mellitus. The opportunity of continuous glucose monitoring allows further improvement in insulin dose adaptation in patients on intensified conventional insulin treatment and those on insulin pumps. Connecting continuous glucose sensors with insulin pumps allow for continuous adaptation of insulin supply based on actual glucose readings and might pave the way to an artificial pancreas. With all these progress in glucose sensing technologies, it is still essential to teach the patients about the meaning of their glucose readings, and to draw adequate therapeutical conclusions.
Schlüsselwörter
Glukosemessung - Uringlukose - Blutglukose - interstitielle Glukose - Glukosekontrollierte Insulintherapie
Keywords
glucose measurement - urinary glucose - blood glucose - interstitial glucose - glucose-controlled insulin treatment
